Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 AUG 3 ... strategies based on heterologous prime-boost protocols using Mycobacterium bovis bacillusCalmette-Guerin (BCG) to prime and modified vaccinia virus Ankara strain (MVA85A) or ... of BCG-vaccinated calves compared to those in BCG-only-vaccinated animals. Analysis of vaccine-induced immunity identified memory responses measured by cultured enzyme-linked ...
2009 OCT 12 ... amazonensis PH8 plus L. (Viannia) braziliensis M2903 monovalent vaccines associated with BacillusCalmette-Guerin (BCG) was established, one round of which also included an M2903 vaccine ...
2009 JUL 27 ... Pike, Bethesda, MD 20814, USA. Keywords: Australia, Sydney, BCG Vaccines, BacillusCalmette-Guerin Vaccines, Biotechnology, Cutaneous Tuberculosis, Immunization, ... vaccination to adequately control the spread of tuberculosis is a limited ability of the vaccine to induce effective CD8 T cell responses. However, the relative capacity of the BCG ...
2009 OCT 12 ... messenger RNA (mRNA) expression was investigated in the spleen and lung digest cells of bacillusCalmette-Guerin (BCG)-vaccinated and non-vaccinated guinea pigs following low-dose, ... our results suggest that type I cytokine mRNA expression is not associated with vaccine-induced protection in the low-dose guinea pig model of tuberculosis." ...
2009 JUN 22 ... Washington, DC 20036-2904, USA.
Keywords: Ireland, Dublin, BCG Vaccines, BacillusCalmette-Guerin Vaccines, Biotechnology, Cutaneous Tuberculosis, Immunization, ... "To further unravel the mechanisms responsible for attenuation of the tuberculosis vaccine Mycobacterium bovis BCG, comparative genomics was used to identify single nucleotide ...
2009 NOV 23 ... induced significantly stronger specific antibodies than the classical TB vaccine-BCG (bacillusCalmette-Guerin). Compared with BCG, the stimulation index in the splenolymphocyte ...
2009 NOV 1 ... OX5 1GB, Oxon, England. Keywords: Australia, Parkville, BCG Vaccines, BacillusCalmette-Guerin Vaccines, Biotechnology, Cutaneous Tuberculosis, Drugs, Immunization, ... girl was inadvertently immunised with an excessively large dose of BCG-Connaught vaccine (1.0 ml instead of 0.1 ml). Examination of the patient a few hours later revealed a ...
2009 AUG 10 ... USA. Keywords: People's Republic of China, Shenzhen, BCG Vaccines, BacillusCalmette-Guerin Vaccines, Biotechnology, Cutaneous Tuberculosis, Immunization, ... TB infections." Chen and colleagues published their study in Clinical and Vaccine Immunology (Diagnosis of Active Tuberculosis in China Using an In-House Gamma Interferon ...
2009 AUG 3 ... Tokyo, Tuberculosis Therapy, AIDS, Acquired Immunodeficiency Syndrome, BCG Vaccines, BacillusCalmette-Guerin Vaccines, Chemotherapy, Cutaneous Tuberculosis, Diagnostics, Drug ... Treatment, Vaccination, Virology. This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2009, AIDS Vaccine Week via ...
2009 MAY 18 ... "The bacillusCalmette-Guerin ( BCG) strain of Mycobacterium bovis is used in many parts of the world ... ( BCG) strain of Mycobacterium bovis is used in many parts of the world as a vaccine against Mycobacterium tuberculosis. Some epidemiological evidence has suggested that BCG ...
2009 JUL 13 ... to record social status, country of birth, history of prior TST, tuberculosis (TB), BCG (Bacillus of Calmette-Guerinvaccine), and any cause of immuno-suppression. LTBI was defined as ...
2009 OCT 5 ... DC 20036-2904, USA. Keywords: United States, Ames, BCG Vaccines, BacillusCalmette-Guerin Vaccines, Biotechnology, Immunization, Immunology, Interferon, ... into mechanisms of pathogen control and may provide clues to development of effective vaccine strategies. WTD were vaccinated with either M. bovis BCG strain Pasteur or BCG strain ...
2009 MAY 4 ... OX5 1GB, Oxon, England.
Keywords: United States, Bethesda, BCG Vaccines, BacillusCalmette-Guerin Vaccines, Biotechnology, Central Nervous System Disease, Cutaneous ... is responsible for nearly two million deaths every year globally. A single licensed vaccine derived from Mycobacterium bovis, bacille Calmette-Guerin (BCG) administered perinatally ...
2009 JUN 8 ... elicited by Ag85B DNA alone, which was not significantly different from that provided by BacillusCalmette-Guerin (BCG)," wrote W.H. Yao and colleagues, Wuhan University, Medical ... The researchers concluded: "These results suggested that DNA vaccine consisting of BVP22 and Ag85B-encoding DNA enhanced immune response and protection ...
2009 NOV 23 ... from Berlin, Germany, "Concerns about the safety and efficacy of Mycobacterium bovis bacillusCalmette-Guerin (BCG) emphasize the need for alternative tuberculosis (TB) vaccines. DNA ... and cellular immunology have paved the way toward the rational design of an efficacious vaccine. We exploited self-cleaving peptide 2A from the foot-and-mouth disease virus, because of ...
2009 JUN 15 ... CD8(+) T cell responses in the combined DNA vaccine group were higher than either the BacillusCalmette-Guerin (BCG)-positive or S19-positive control group. Likewise, more calves in ...
2009 AUG 10 ... with Mycobacterium tuberculosis at levels that are comparable to or better than those of bacillusCalmette-Guerin. Characterization of the CD4 memory T cells by multicolor flow cytometry ... global health problems. In the present study, we demonstrate that a tuberculosis subunit vaccine, Ag85B-ESAT-6/CAF01 (where ESAT-6 is early secreted antigenic target of 6 kDa and CAF01 ...
2009 JUN 1 ... The magnitude of IFN-gamma response was comparable to previous trials of MVA85A in bacillusCalmette-Guerin-vaccinated individuals. Antigen 85A-specific polyfunctional CD4(+) T ... " An effective new tuberculosis (TB) vaccine regimen must be safe in individuals with latent TB infection (LTBI) and is a priority ...
2009 OCT 12 ... a unique adjuvant component able to enhance efficacy of the existing Mycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine to protect against murine model of tuberculosis. Although ... OX2 6DP, England. Keywords: United States, Houston, Life Sciences, Bacillus Calmette-Guerin Vaccines, BCG Vaccines, Vaccination, Immunization, Cutaneous Tuberculosis, Mycobacterium ...
